Drug Shortage Report for TRIESENCE
| Report ID | 83368 |
| Drug Identification Number | 02368676 |
| Brand name | TRIESENCE |
| Common or Proper name | TRIESENCE 1ML SUSP X12 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TRIAMCINOLONE ACETONIDE |
| Strength(s) | 40MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVITREAL |
| Packaging size | 12 |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-06-03 |
| Actual start date | 2019-05-27 |
| Estimated end date | 2020-08-31 |
| Actual end date | 2020-09-02 |
| Shortage status | Resolved |
| Updated date | 2020-09-08 |
| Company comments | Production constraints limit product availability. Inventory being periodically released based on stock received. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-05-07 | English | Compare |
| v2 | 2019-05-07 | French | Compare |
| v3 | 2019-05-10 | English | Compare |
| v4 | 2019-05-10 | French | Compare |
| v5 | 2019-05-10 | English | Compare |
| v6 | 2019-05-10 | French | Compare |
| v7 | 2019-06-04 | English | Compare |
| v8 | 2019-06-04 | English | Compare |
| v9 | 2019-06-04 | French | Compare |
| v10 | 2019-08-12 | English | Compare |
| v11 | 2019-08-12 | French | Compare |
| v12 | 2019-09-25 | English | Compare |
| v13 | 2019-09-25 | French | Compare |
| v14 | 2020-01-10 | English | Compare |
| v15 | 2020-01-10 | French | Compare |
| v16 | 2020-04-17 | English | Compare |
| v17 | 2020-04-22 | English | Compare |
| v18 | 2020-04-22 | French | Compare |
| v19 | 2020-06-03 | English | Compare |
| v20 | 2020-06-05 | English | Compare |